Hoth Therapeutics, Inc. Profile Avatar - Palmy Investing

Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders as…

Biotechnology
US, New York [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Hoth Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Hoth Therapeutics, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Hoth Therapeutics, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of HOTH's Analysis
CIK: 1711786 CUSIP: 44148G105 ISIN: US44148G2049 LEI: - UEI: -
Secondary Listings
HOTH has no secondary listings inside our databases.